We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 546

USDA invests $25 million in bioenergy research
  • Shook Hardy & Bacon LLP
  • USA
  • January 24 2013

According to Agriculture Secretary Tom Vilsack, the U.S. Department of Agriculture (USDA) has selected four projects that will receive a total of $25


USPTO issues final rule to reflect patent term adjustment revisions
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

The U.S. Patent and Trademark Office (USPTO) has issued a final rule to implement revisions to the patent term adjustment provisions under the


Gelesis raises $12 million to advance obesity pill
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

Weight-loss treatment developer Gelesis, Inc. has completed a $12-million financing round. Led by PureTech, which founded Gelesis in 2006, and the


News bytes
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

The U.S. Patent and Trademark Office solicits comments on the estimated time and cost burdens of the revision of a currently approved collection of


Compounding Pharmacy reaches $100-million settlement over meningitis outbreak
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

A trustee has filed a motion requesting court approval of a bankruptcy plan that would require New England Compounding Pharmacy owners and executives


Proteon secures $45 million to fund kidney drug testing
  • Shook Hardy & Bacon LLP
  • USA
  • May 22 2014

Proteon Therapeutics Inc., a Waltham, Massachusetts-based developer of treatments for patients with kidney and vascular diseases, has reportedly


FDA launches blog to provide insights into public health issues
  • Shook Hardy & Bacon LLP
  • USA
  • January 19 2012

The Food and Drug Administration (FDA) has launched a blog that, in the words of Commissioner Margaret Hamburg, will provide “insights on some of the most pressing public health issues of the day.”


N e w s b y t e s
  • Shook Hardy & Bacon LLP
  • USA
  • January 19 2012

The Food and Drug Administration requests comments by April 26, 2012, on its “Draft Guidance for Industry and Food and Drug Administration Staff; The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications 510(k).”


Congress continues to address reauthorization of FDA user fee law
  • Shook Hardy & Bacon LLP
  • USA
  • January 19 2012

With a number of hearings scheduled before House committees in February 2012, Congress is apparently on track to complete work on measures that would reauthorize the Food and Drug Administration (FDA) to collect user fees before the current law expires on September 30


USPTO rolls out rulemaking notices to implement America Invents Act
  • Shook Hardy & Bacon LLP
  • USA
  • January 19 2012

The U.S. Patent and Trademark Office (USPTO) issued several notices in the January 5, 2012, Federal Register, concerning proposed rulemakings that would implement procedural changes required under the America Invents Act